Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis by Xiao Han, Xiao Han, Haidong Zhang, Haidong Zhang, Kai Sun, Kai Sun, Jing Li, Jing Li, Wanjuan Wu, Wanjuan Wu, Kai Liu, Kai Liu, Zhenkun Yu, Zhenkun Yu

Get full text